Dianthus Therapeutics (NASDAQ:DNTH) executives used a Biotech Summit 2026 discussion to outline upcoming clinical catalysts ...
Medexus Pharmaceuticals (TSE:MDP) highlighted continued momentum for its U.S. launch of GRAFAPEX while reporting lower year-over-year revenue and earnings in its fiscal third quarter of 2026, ...
Meanwhile, key senators say they won't support a short-term spending bill to avoid a shutdown of the Department of Homeland ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results